Skip to content

Carcinoma In Situ Of Urethra C4721449

Published: July 22, 2026Updated: August 20, 2026

An early-stage cancer limited to the inner lining of the urethra, the tube that carries urine from the bladder. Surgical removal of affected tissue is typically performed.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D02.1, D01.2, D07.1
ICD-11
3A00.0
Body system
genitourinary
Severity
moderate
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Gross hematuria

Generalized symptoms

(genitourinary)

Noticeable symptoms that may vary in intensity over time.

Frequency: Varies

Dysuria

(genitourinary)

Urethral discharge

(genitourinary)

Weak urinary stream

(genitourinary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Transurethral resection of urethra

Endoscopic removal of carcinoma in situ of the urethra using specialized instruments passed through the urethra. Allows tissue diagnosis and complete excision of visible lesions.

surgical
3

Urethroscopic surveillance program

Regular endoscopic monitoring of the urethra for recurrence following treatment. Includes urine cytology and direct visualization at follow-up intervals.

monitoring

Additional treatment options

Topical 5-fluorouracil therapy

Application of 5-FU cream directly to urethral mucosa to treat surface carcinoma in situ. This approach targets abnormal cells while minimizing systemic side effects.

procedure

Topical BCG immunotherapy

Intraurethral instillation of BCG vaccine to stimulate local immune response against carcinoma in situ cells. May be used for refractory cases.

procedure

Urethrectomy

Surgical removal of the urethra for extensive carcinoma in situ that cannot be controlled with conservative approaches. May be partial or total depending on disease extent.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Carcinoma In Situ Of Urethra C4721449?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Carcinoma In Situ Of Urethra C4721449. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy